- Home
- CDIO vs CARA Comparison
CDIO vs CARA Comparison
Compare CDIO & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- CARA
- Stock Information
- Founded
- CDIO 2017
- CARA 2004
- Country
- CDIO United States
- CARA United States
- Employees
- CDIO N/A
- CARA 55
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- CARA Health Care
- Exchange
- CDIO Nasdaq
- CARA Nasdaq
- Market Cap
- CDIO 23.6M
- CARA 23.2M
- IPO Year
- CDIO N/A
- CARA 2014
- Fundamental
- Price
- CDIO $0.33
- CARA $4.95
- Analyst Decision
- CDIO Buy
- CARA Hold
- Analyst Count
- CDIO 1
- CARA 3
- Target Price
- CDIO $2.00
- CARA $12.00
- AVG Volume (30 Days)
- CDIO 807.0K
- CARA 10.4K
- Earning Date
- CDIO 05-14-2025
- CARA 05-12-2025
- Dividend Yield
- CDIO N/A
- CARA N/A
- EPS Growth
- CDIO N/A
- CARA N/A
- EPS
- CDIO N/A
- CARA N/A
- Revenue
- CDIO $34,890.00
- CARA $7,137,000.00
- Revenue This Year
- CDIO $1,434.82
- CARA N/A
- Revenue Next Year
- CDIO $4,661.91
- CARA N/A
- P/E Ratio
- CDIO N/A
- CARA N/A
- Revenue Growth
- CDIO 104.45
- CARA N/A
- 52 Week Low
- CDIO $0.19
- CARA $2.71
- 52 Week High
- CDIO $1.77
- CARA $11.39
- Technical
- Relative Strength Index (RSI)
- CDIO 35.24
- CARA 49.07
- Support Level
- CDIO $0.30
- CARA $4.88
- Resistance Level
- CDIO $0.40
- CARA $5.15
- Average True Range (ATR)
- CDIO 0.05
- CARA 0.25
- MACD
- CDIO -0.01
- CARA -0.04
- Stochastic Oscillator
- CDIO 21.16
- CARA 25.89
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.